NVCT Nuvectis Pharma20.11-1.49 (-6.9%)
Premarket Decliner
NVCT Nuvectis Pharma21.60+0.08+0.4%
Premarket:17.83-3.77 (-17.5%)
Nuvectis Pharma Reports Second Quarter 2026 Financial Results and Business Highlights
Globe NewswireTue, 4-Aug 8:00 AM
NVCT Nuvectis Pharma19.31-9.22 (-32.3%)
Premarket Decliner
NVCT Nuvectis Pharma28.53+1.34+4.9%
Premarket:21.75-6.78 (-23.8%)
Nuvectis Pharma Announces Pricing of $100 Million Public Offering of Common Stock
Globe NewswireMon, 29-Jun 10:30 PM
NVCT Nuvectis Pharma10.81+0.18 (+1.7%)
NVCT Nuvectis Pharma11.93+1.03 (+9.5%)